On Monday, the stock market will take the day off to shake the confetti out of its hair. But on Tuesday, it'll be back to business as usual on Wall Street. Here are some of the items that will shape the first trading week of 2012.
Forecasting which technologies will succeed is always hazardous, but it proved especially difficult in 2010, a year full of surprises -- and also several disappointments. Facebook blew away even the most optimistic expectations for the year. Google Buzz? Not so much.
Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; and Novartis announced its plans for long-term growth.
